Ariel Berlinski
Sourced from institutional research profiles (UAMS TRI or ARA).
Professor
Also affiliated: Arkansas Children's Hospital (2006–2026); Central Michigan University (2015); Baylor College of Medicine (1998–2002); University of Arkansas Medical Center (2007–2021); Johnson University (2026); Arkansas Cardiology (2024); Arkansas Children's Nutrition Center (2017–2025); Arkansas Department of Agriculture (2017)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Ariel Berlinski's research focuses on aerosol therapy and respiratory care, particularly in pediatric and critically ill populations. His work investigates strategies for drug delivery through various modes of respiratory support, including ventilator circuits and nebulizer systems. Berlinski has studied the long-term safety and efficacy of treatments for cystic fibrosis, evaluating outcomes in individuals aged 12 and older.
His research extends to clinical practice guidelines, including the management of pediatric patients receiving oxygen in acute care settings. Berlinski also examines the implementation of protocols for spirometry and asthma education in outpatient primary care, as well as the use of home spirometry in children with cystic fibrosis. His scholarship includes studies on nutritional status and its association with cystic fibrosis-related diabetes.
Berlinski is a highly cited researcher with an h-index of 25 and over 170 publications. He collaborates with researchers at the University of Arkansas for Medical Sciences, including K. Agoramurthi, Z. Ghazala, Tamara T. Perry, and L Denise Willis, with whom he has co-authored multiple publications. He leads a research group focused on these areas.
Metrics
- h-index: 25
- Publications: 172
- Citations: 1,919
Selected Publications
-
Home Spirometry as a Clinical Trial Endpoint in People with Cystic Fibrosis: Results of the OUTREACH Study (2026)
-
Understanding Nebulizer Utilization by Patients and Healthcare Providers: A COPD Foundation Nebulizer Consortium Survey Study (2026)
-
Comparing a Guideline-Based Mobile Health Intervention Versus Usual Care for High-Risk Adolescents With Asthma: Protocol of a Randomized Controlled Trial (2025)
-
Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease (2025)
-
Mobile Health App for Adolescent Asthma Self-Management: Development and Usability Study of the Pulmonary Education and Knowledge Mobile Asthma Action Plan (2025)
-
Use of Digital Health in Pediatric Asthma (2025)
-
Aerosol Delivery Challenges and Strategies for Pediatric Asthma (2025)
-
Impact of Practice Changes for Frequency of Heated Circuit Replacement (2024)
-
Aerosol Delivery Via Heated Tracheostomy Collar in a Spontaneously Breathing Pediatric Model (2024)
-
Delivery of Continuous Albuterol During Emergency Medical Services Transport (2024)
-
Comparison of Noninvasive Inhaled Nitric Oxide Delivery Methods in an Infant Model (2024)
-
Discharge Transportation for Initial Hospital Discharge of Tracheostomized Ventilator-Dependent Children (2024)
-
Drug Delivery via Intrapulmonary Percussion Ventilator: Time to Follow Queen Elsa’s Advice (2024)
-
Incorporating the perspectives of participants and research coordinators on home spirometry into clinical trial design: The example of the OUTREACH study (2024)
-
EPS4.07 Validation of home spirometry as a CF clinical trial endpoint: results of the OUTREACH study (2024)
Grants & Funding
As listed on this researcher's institutional profile.
- CFFT Therapeutics Dev Center Renewal 2014 Cystic Fibrosis Foundation
- CFT Therapeutic Development Center Renewal 2018 - Continuation - Continuation Cystic Fibrosis Foundation
- Cystic Fibrosis Foundation Therapeutics Development-Renewal 2024-2025 Cystic Fibrosis Foundation
- GR039172 Berlinski CFF Database UAMS ACHRI Flow Through
- Cystic Fibrosis Foundation Therapeutics Developmen-Renewal Cystic Fibrosis Foundation
- CFT Therapeutic Development Center Renewal 2021 Cystic Fibrosis Foundation
- GR036169 Berlinski ACRI OUTREACH Study UAMS ACHRI Flow Through
Collaboration Network
Top Collaborators
- Implementation of a Respiratory Therapist–Driven Protocol for Spirometry and Asthma Education in a Pediatric Out-Patient Primary Care Setting
- Safe and Effective Use of Score-Based Continuous Albuterol Therapy in a Pathway for Treatment of Pediatric Asthma Exacerbation
- Albuterol Delivery During Invasive Mechanical Ventilation via In-Line Intrapulmonary Percussive Ventilation in a Pediatric Lung Model
- Curriculum and Competency Evaluation in Respiratory Therapy Entry-to-Practice Programs
- Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease
- Necrotizing Pneumonia in a Young Adult With Cystic Fibrosis
- Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients
- Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease
- EPS4.07 Validation of home spirometry as a CF clinical trial endpoint: results of the OUTREACH study
- 182 A qualitative needs assessment of people with cystic fibrosis and research coordinators to inform future clinical trials incorporating home spirometry as an endpoint
- 118 Research coordination perceptions of a coached home spirometry protocol: ongoing experiences with the OUTREACH study
- EPS4.07 Validation of home spirometry as a CF clinical trial endpoint: results of the OUTREACH study
- 182 A qualitative needs assessment of people with cystic fibrosis and research coordinators to inform future clinical trials incorporating home spirometry as an endpoint
- 118 Research coordination perceptions of a coached home spirometry protocol: ongoing experiences with the OUTREACH study
- EPS4.07 Validation of home spirometry as a CF clinical trial endpoint: results of the OUTREACH study
- 182 A qualitative needs assessment of people with cystic fibrosis and research coordinators to inform future clinical trials incorporating home spirometry as an endpoint
- 118 Research coordination perceptions of a coached home spirometry protocol: ongoing experiences with the OUTREACH study
- Necrotizing Pneumonia in a Young Adult With Cystic Fibrosis
- 455 Performance of a breath-enhanced nebulizer after repeated cycles of thermal or chemical disinfection
- Effect of Disinfection Method and Testing Methodology on the Performance of a Breath-Enhanced Jet Nebulizer
- Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease
- Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients
- Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease
- Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease
- Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients
- Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease
- Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease
- Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients
- Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease
- Effect of In-Line Intrapulmonary Percussive Ventilation on Respiratory Pressures During Simulated Pediatric Invasive Ventilation
- Practices for High Frequency Chest Compression in Children
- EPS4.07 Validation of home spirometry as a CF clinical trial endpoint: results of the OUTREACH study
- 182 A qualitative needs assessment of people with cystic fibrosis and research coordinators to inform future clinical trials incorporating home spirometry as an endpoint
- Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials
- EPS4.07 Validation of home spirometry as a CF clinical trial endpoint: results of the OUTREACH study
- Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials
- Incorporating the perspectives of participants and research coordinators on home spirometry into clinical trial design: The example of the OUTREACH study
- EPS4.07 Validation of home spirometry as a CF clinical trial endpoint: results of the OUTREACH study
- 118 Research coordination perceptions of a coached home spirometry protocol: ongoing experiences with the OUTREACH study
- Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients
- Impact of Using New Formula for Calculation of Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease
Similar Researchers
Based on overlapping research topics